This role oversees balance sheet forecasting and reporting responsibilities for US Therapeutics, Global DSO reporting, Global intangibles testing, as well as supporting our SOX program and various audit engagements.  The incumbent will partner closely with Commercial Finance, Corporate Accounting and Corporate FP&A, Operations Finance and other cross-functional stakeholders to deliver actionable insights, enhance our compliance framework, and support strategic decision-making.

Key Responsibilities:

• Lead a team of finance professionals by aligning goals and priorities, motivating the team, and supporting execution on core deliverables.
• Manage balance sheet consolidation activities and account ownership for the US Therapeutics.  This includes coordinating balance sheet reporting and planning across actuals, LBE, plan, and LRP cycles.
• Lead U.S. Tx AR/DSO reporting, analysis, and consolidation in su...